Skip to content

Drug interactions

Givinostat + Metformin-repaglinide

Severity: Minor

Givinostat and Metformin-repaglinide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Givinostat is a weak inhibitor of CYP3A4 and of renal transporters involved in metformin handling. Exposure to repaglinide and metformin may rise modestly. The effect is usually small, but increased hypoglycemia or metformin adverse effects are possible.

What this interaction means in plain words

Givinostat and Metformin-repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Givinostat belongs to Miscellaneous; Metformin-repaglinide belongs to Endocrine.

Evidence level: Low

Why it happens

Weak inhibition of CYP3A4 (reducing repaglinide metabolism) and of renal organic cation transport (reducing metformin clearance).

What to do

Monitor blood glucose when givinostat is started or stopped. Reduce the antidiabetic dose if hypoglycemia or metformin intolerance appears.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Givinostat and Metformin-repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Givinostat with Metformin-repaglinide?

MediHelp rates the interaction as minor. Givinostat and Metformin-repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Givinostat is a weak inhibitor of CYP3A4 and of renal transporters involved in metformin handling. Exposure to repaglinide and metformin may rise modestly. The effect is usually small, but increased hypoglycemia or metformin adverse effects are possible.

How serious is the interaction between Givinostat and Metformin-repaglinide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when givinostat is started or stopped. Reduce the antidiabetic dose if hypoglycemia or metformin intolerance appears.

What other medicines interact with Metformin-repaglinide?

MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in